The Physician Payment Sunshine Act was meant to shed light on the financial relationship between drugmakers, biotech, and medical device companies whether those payments be for general or research purposes.
The Centers for Medicare and Medicaid Services has recorded these payments now for two complete years in a row with partial data available for 2013.
